These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 1531588)
21. The effect of exercise on thrombin and plasmin generation in middle-aged men. Small M; Simpson I; McGhie I; Douglas JT; Lowe GD; Forbes CD Haemostasis; 1987; 17(6):371-6. PubMed ID: 2962911 [TBL] [Abstract][Full Text] [Related]
22. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin. Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636 [TBL] [Abstract][Full Text] [Related]
23. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain. Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490 [TBL] [Abstract][Full Text] [Related]
24. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. Hogg PJ; Jackson CM J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105 [TBL] [Abstract][Full Text] [Related]
25. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide. Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702 [TBL] [Abstract][Full Text] [Related]
26. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site. Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046 [TBL] [Abstract][Full Text] [Related]
27. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen. Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434 [TBL] [Abstract][Full Text] [Related]
28. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. Higgins DL; Lewis SD; Shafer JA J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903 [TBL] [Abstract][Full Text] [Related]
29. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain. Odrljin TM; Shainoff JR; Lawrence SO; Simpson-Haidaris PJ Blood; 1996 Sep; 88(6):2050-61. PubMed ID: 8822924 [TBL] [Abstract][Full Text] [Related]
30. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases. Mombelli G; Monotti R; Haeberli A; Straub PW Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428 [TBL] [Abstract][Full Text] [Related]
31. The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product. Applegate D; Steben LS; Hertzberg KM; Grieninger G Blood; 2000 Apr; 95(7):2297-303. PubMed ID: 10733499 [TBL] [Abstract][Full Text] [Related]
32. A re-examination of the cleavage of fibrinogen and fibrin by plasmin. Ferguson EW; Fretto LJ; McKee PA J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232 [TBL] [Abstract][Full Text] [Related]
33. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337 [TBL] [Abstract][Full Text] [Related]
34. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization. Mosesson MW; Hernandez I; Siebenlist KR Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147 [TBL] [Abstract][Full Text] [Related]
35. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products. Vila V; Regañón E; Aznar J; Navarro G; Salas M Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261 [TBL] [Abstract][Full Text] [Related]
36. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity? Marongiu F; Conti M; Mameli G; Sorano GG; Cossu E; Cirillo R; Balestrieri A Thromb Res; 1990 Apr; 58(2):91-9. PubMed ID: 1693451 [TBL] [Abstract][Full Text] [Related]
37. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen. Sato H; Swadesh JK Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652 [TBL] [Abstract][Full Text] [Related]
38. Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule. Maeda N; Seike M; Kume S; Takaku T; Shiga T Biochim Biophys Acta; 1987 Nov; 904(1):81-91. PubMed ID: 2959322 [TBL] [Abstract][Full Text] [Related]
39. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin. Carrell N; McDonagh J Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210 [TBL] [Abstract][Full Text] [Related]
40. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin]. Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]